In this study, LC-MS/MS plasma proteomics application in CRC patients identified novel protein signatures compared to healthy subjects including complement proteins as well as proteins such as SAA4 and LBP associated with pro-inflammatory conditions. This evidence concerns the gene LBP and colorectal carcinoma.